{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:08:40Z","timestamp":1792505320290,"version":"4.5.0"},"reference-count":16,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1517\/14740338.4.4.637","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T15:04:29Z","timestamp":1121180669000},"page":"637-641","source":"Crossref","is-referenced-by-count":145,"title":["Adalimumab: a review of side effects"],"prefix":"10.1517","volume":"4","author":[{"given":"Noah","family":"Scheinfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2005,7,12]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410017275"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200403000-00006"},{"key":"CIT0006","first-page":"112","volume":"63","author":"EFDE MN","year":"2005","journal-title":"Neth. I Med."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000124490.27666.B2"},{"key":"CIT0008","first-page":"123","volume":"86","author":"ANKER SD","year":"2002","journal-title":"bit.j Cardiol"},{"key":"CIT0009","first-page":"3133","volume":"107","author":"CHUNG ES","year":"2003","journal-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.09.039"},{"key":"CIT0013","first-page":"R545\u2013R551","volume":"7","author":"DE BANDT M","year":"2005","journal-title":"LE LOET X et al.: Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res. Ther."},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-003-0040-8"},{"key":"CIT0020","first-page":"1412","volume":"50","author":"GENOVESE MC","year":"2004","journal-title":"Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis Rheum."},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.11.1425"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1002\/art.10939"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1002\/art.20311"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200407000-00002"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1002\/art.20155"},{"key":"CIT0028","first-page":"137","volume":"61","author":"DEN BROEDER AA","year":"2003","journal-title":"Neth. Med."}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.4.4.637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T09:06:20Z","timestamp":1481619980000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.4.4.637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,7,12]]},"published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1517\/14740338.4.4.637"],"URL":"https:\/\/doi.org\/10.1517\/14740338.4.4.637","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}